Searching for SARS-COV-2 on Particulate Matter: A Possible Early Indicator of COVID-19 Epidemic Recurrence

被引:87
|
作者
Setti, Leonardo [1 ]
Passarini, Fabrizio [2 ]
De Gennaro, Gianluigi [3 ]
Barbieri, Pierluigi [4 ]
Pallavicini, Alberto [5 ]
Ruscio, Maurizio [6 ]
Piscitelli, Prisco [7 ,8 ]
Colao, Annamaria [8 ]
Miani, Alessandro [7 ,8 ,9 ]
机构
[1] Univ Bologna, Dept Ind Chem, I-40136 Bologna, Italy
[2] Univ Bologna, Interdept Ctr Ind Res Renewable Sources Environm, I-47921 Rimini, Italy
[3] Univ Bari, Dept Biol, I-70121 Bari, Italy
[4] Univ Trieste, Dept Chem & Pharmaceut Sci, I-34127 Trieste, Italy
[5] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy
[6] Univ Hosp Giuliano Isontina ASU GI, Div Lab Med, I-34127 Trieste, Italy
[7] Italian Soc Environm Med SIMA, I-20149 Milan, Italy
[8] Univ Naples Federico II, UNESCO Chair Hlth Educ & Sustainable Dev, I-80131 Naples, Italy
[9] Univ Milan, Dept Environm Sci & Policy, Via Celoria 2, I-20133 Milan, Italy
关键词
COVID-19; RNA; Particulate Matter; Indicator; Epidemic; Relapse; VIRUS;
D O I
10.3390/ijerph17092986
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A number of nations were forced to declare a total shutdown due to COVID-19 infection, as extreme measure to cope with dramatic impact of the pandemic, with remarkable consequences both in terms of negative health outcomes and economic loses. However, in many countries a "Phase-2" is approaching and many activities will re-open soon, although with some differences depending on the severity of the outbreak experienced and SARS-COV-2 estimated diffusion in the general population. At the present, possible relapses of the epidemic cannot be excluded until effective vaccines or immunoprophylaxis with human recombinant antibodies will be properly set up and commercialized. COVD-19-related quarantines have triggered serious social challenges, so that decision makers are concerned about the risk of wasting all the sacrifices imposed to the people in these months of quarantine. The availability of possible early predictive indicators of future epidemic relapses would be very useful for public health purposes, and could potentially prevent the suspension of entire national economic systems. On 16 March, a Position Paper launched by the Italian Society of Environmental Medicine (SIMA) hypothesized for the first time a possible link between the dramatic impact of COVID-19 outbreak in Northern Italy and the high concentrations of particulate matter (PM10 and PM2.5) that characterize this area, along with its well-known specific climatic conditions. Thereafter, a survey carried out in the U.S. by the Harvard School of Public Health suggested a strong association between increases in particulate matter concentration and mortality rates due to COVID-19. The presence of SARS-COV-2 RNA on the particulate matter of Bergamo, which is not far from Milan and represents the epicenter of the Italian epidemic, seems to confirm (at least in case of atmospheric stability and high PM concentrations, as it usually occurs in Northern Italy) that the virus can create clusters with the particles and be carried and detected on PM10. Although no assumptions can be made concerning the link between this first experimental finding and COVID-19 outbreak progression or severity, the presence of SARS-COV-2 RNA on PM10 of outdoor air samples in any city of the world could represent a potential early indicator of COVID-19 diffusion. Searching for the viral genome on particulate matter could therefore be explored among the possible strategies for adopting all the necessary preventive measures before future epidemics start.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment Reply
    McCullough, Peter A.
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (03): : E222 - E223
  • [42] Computation to Fight SARS-CoV-2 (COVID-19)
    Brogi, Simone
    Calderone, Vincenzo
    COMPUTATION, 2023, 11 (09)
  • [43] SARS-CoV-2 reinfection and COVID-19 severity
    Nguyen, Nhu Ngoc
    Houhamdi, Linda
    Hoang, Van Thuan
    Delerce, Jeremy
    Delorme, Lea
    Colson, Philippe
    Brouqui, Philippe
    Fournier, Pierre-Edouard
    Raoult, Didier
    Gautret, Philippe
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 894 - 901
  • [44] SARS-CoV-2/COVID-19: a primer for cardiologists
    A. A. F. de Vries
    Netherlands Heart Journal, 2020, 28 : 366 - 383
  • [45] Decoding Covid-19 with the SARS-CoV-2 Genome
    Phoebe Ellis
    Ferenc Somogyvári
    Dezső P. Virok
    Michela Noseda
    Gary R. McLean
    Current Genetic Medicine Reports, 2021, 9 : 1 - 12
  • [46] In Focus: SARS-CoV-2 and the COVID-19 Pandemic
    Giunta, Riccardo E.
    HANDCHIRURGIE MIKROCHIRURGIE PLASTISCHE CHIRURGIE, 2020, 52 (03) : 220 - 220
  • [47] The evolution of SARS-CoV-2 and the COVID-19 pandemic
    Si, Yuanfang
    Wu, Weidong
    Xue, Xia
    Sun, Xiangdong
    Qin, Yaping
    Li, Ya
    Qiu, Chunjing
    Li, Yingying
    Zhuo, Ziran
    Mi, Yang
    Zheng, Pengyuan
    PEERJ, 2023, 11
  • [48] The evolution of SARS-CoV-2 and the COVID-19 pandemic
    Si, Yuanfang
    Wu, Weidong
    Xue, Xia
    Sun, Xiangdong
    Qin, Yaping
    Li, Ya
    Qiu, Chunjing
    Li, Yingying
    Zhuo, Ziran
    Mi, Yang
    Zheng, Pengyuan
    PEERJ, 2023, 11
  • [49] COVID-19: implications of SARS-CoV-2 in Colombia
    Almeida-Espinosa, Alexander
    Sarmiento-Ardila, Jorge A.
    GACETA MEDICA DE MEXICO, 2020, 156 (04): : 334 - 338
  • [50] Overview of SARS-CoV-2 and COVID-19 Vaccine
    Alhaibil, Nada Abdullah
    BAHRAIN MEDICAL BULLETIN, 2021, 43 (02) : 511 - 515